The Valley Desk

NCT03730662 · Interventional trial

A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk

Overall registry status Completed

Phase 3

Conditions Type 2 Diabetes Mellitus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov